Skip Navigation

Journal of Intellectual Property Law & Practice 2009 4(7):452-454; doi:10.1093/jiplp/jpp093
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press. All rights reserved.

JIPLP Express

JIPLP Express

A rapid-read overview of the main items in this issue

The first 150 words of the full text of this article appear below.


    Current Intelligence
 
Patents
Ever broader border controls? There has been substantial political fallout from the recent in-transit detention of generic medicines by the Dutch customs authorities on suspicion of an infringement of patent rights under Council Regulation 1383/2003. (p. 455)

Paediatric extensions: the requirement of a compliance statement. Taking a narrow interpretation of what is meant by a statement indicating compliance with an agreed completed paediatric investigation plan (PIP), the UK Intellectual Property Office has held that a valid application for a paediatric extension must include an authorization containing such a statement and that therefore a positive opinion of the Paediatric Committee of the EMEA, as such, is not suitable as a means to meet this requirement. (p. 457)

House of Lords addresses ‘ Biogen insufficiency’. Simple patent product claims are not caught by the principles of Biogen insufficiency, but the precise scope of those principles is left unclear. (p. 459)

Trade marks
Intellectual Property . . . [Full Text of this Article]

Copyright
Unfair competition

    Practice Point
 
Parody as fair dealing in Canada: a guide for lawyers and judges (p. 468)

    Articles
 
IP and joint ventures: protection of IP on exit (p. 473)
Microbicide development: an argument for broadening the experimental use exception (p. 485)
The shape of the Lego brick is free for all to use (p. 499)
The characteristics of technical character and the ongoing saga in the EPO and the English courts (p. 506)

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?